Skip to main content
. 2017 Dec 15;17:855. doi: 10.1186/s12885-017-3811-6

Table 2.

Univariate analysis of clinicopathologic variables in 100 patients with LSC (log-rank test)

Variable All cases Mean survival(months) Median survival(months) P valuea
Age (years)b 0.439
 ≤ 57 47 47.8 31.0
 >57 53 55.4 18.0
Gender 0.538
 Female 13 37.4 27.0
 Male 87 55.2 25.0
Smoking 0.078
 Yes 76 59.4 43
 No 24 25.1 15.0
Tumor sizec 0.032
 ≤ 4.5 cm 59 65.8 48.0
 >4.5 cm 41 39.5 18.0
T stage 0.033
 T1 And T2 56 63.2 48.0
 T3 And T4 44 44.7 14.0
Lymph node 0.000
 N0 52 74.7 68.0
 N1,N2 And N3 48 31.4 14.0
M stage 0.000
 M0 92 59.9 43.0
 M1 8 12.1 8.0
Therapyd 0.103
 Therapy1 76 62.2 48.0
 Therapy2 19 28.9 21.0
 Therapy3 5 19.0 24.0
Relapse 0.713
 Yes 30 36.4 24.0
 No 70 58.9 43.0
Clinical stage 0.000
 I-II 45 89.8 NR
 III-IV 55 19.5 11.0
p53R2 0.000
 Low expression 42 84.8 NR
 High expression 58 34.7 12.0

aChi-square test

bMean age

cMean tumor size

dTherapy:Therapy1 is Pneumonectomy and lymphadenectomy, Therapy2 is Pneumonectomy;Therapy3 Pneumonectomy and radiotherapy and chemoradiotherapy